Amendment of the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015
3.—(1) The following amendments are made to Schedule 1 to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015(1) (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).
(2) In paragraph 1(a)—
(a)after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;
(b)after “1,4-Butanediol” insert “Butonitazene”;
(c)after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;
(d)after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;
(e)after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)” insert—
“Diphenidine
Ephenidine
Ethyleneoxynitazene”;
(f)after “Etizolam” insert—
“Etodesnitazene (etazene)
Etonitazene”;
(g)after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;
(h)after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;
(i)after “Methcathinone” insert “Methoxyphenidine”;
(j)after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—
“Metodesnitazene (metazene)
Metonitazene”;
(k)after “Propylphenidate” insert “Protonitazene”;
(l)after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—
“N-Desethyl etonitazene
N-Desethylisotonitazene
N-Desethyl protonitazene”;
(m)after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—
“N-Piperidinyl-etonitazene (etonitazepipne)
N-Pyrrolidino-etonitazene (etoniazepyne)
N-Pyrrolidino protonitazene”.
S.I. 2015/704, amended by S.I. 2017/632. There are other amending instruments, but none are relevant.